Similar articles for PMID: 29748614

Year	Number of Results
2001	2
2002	1
2004	1
2006	1
2008	1
2009	2
2010	2
2011	2
2012	3
2013	10
2014	13
2015	16
2016	21
2017	21
2018	29
2019	26
2020	11
2021	7
2022	0

1

Nanovesicle-mediated delivery of anticancer agents effectively induced cell death and regressed intrahepatic tumors in athymic mice.

George J, Yan IK, Patel T. George J, et al. Lab Invest. 2018 Jul;98(7):895-910. doi: 10.1038/s41374-018-0053-4. Epub 2018 May 10. Lab Invest. 2018. PMID: 29748614

2

Functional Doxorubicin-Loaded Omega-3 Unsaturated Fatty Acids Nanoparticles in Reversing Hepatocellular Carcinoma Multidrug Resistance.

Wang C, Wei X, Shao G. Wang C, et al. Med Sci Monit. 2021 Feb 1;27:e927727. doi: 10.12659/MSM.927727. Med Sci Monit. 2021. PMID: 33524008 Free PMC article.

3

Effect of PEG-PDLLA polymeric nanovesicles loaded with doxorubicin and hematoporphyrin monomethyl ether on human hepatocellular carcinoma HepG2 cells in vitro.

Xiang GH, Hong GB, Wang Y, Cheng D, Zhou JX, Shuai XT. Xiang GH, et al. Int J Nanomedicine. 2013;8:4613-22. doi: 10.2147/IJN.S54142. Epub 2013 Dec 2. Int J Nanomedicine. 2013. PMID: 24324333 Free PMC article.

4

Anticancer efficacy of photodynamic therapy with hematoporphyrin-modified, doxorubicin-loaded nanoparticles in liver cancer.

Chang JE, Yoon IS, Sun PL, Yi E, Jheon S, Shim CK. Chang JE, et al. J Photochem Photobiol B. 2014 Nov;140:49-56. doi: 10.1016/j.jphotobiol.2014.07.005. Epub 2014 Jul 24. J Photochem Photobiol B. 2014. PMID: 25090224

5

Galactose-modified selenium nanoparticles for targeted delivery of doxorubicin to hepatocellular carcinoma.

Xia Y, Zhong J, Zhao M, Tang Y, Han N, Hua L, Xu T, Wang C, Zhu B. Xia Y, et al. Drug Deliv. 2019 Dec;26(1):1-11. doi: 10.1080/10717544.2018.1556359. Drug Deliv. 2019. PMID: 31928356 Free PMC article.

6

Hepatoma-targeting and pH-sensitive nanocarriers based on a novel D-galactopyranose copolymer for efficient drug delivery.

Ding Y, Han J, Tian B, Han J, Zhang J, Zheng H, Han Y, Pei M. Ding Y, et al. Int J Pharm. 2014 Dec 30;477(1-2):187-96. doi: 10.1016/j.ijpharm.2014.10.024. Epub 2014 Oct 16. Int J Pharm. 2014. PMID: 25455771

7

Nanomicelles based on a boronate ester-linked diblock copolymer as the carrier of doxorubicin with enhanced cellular uptake.

Xu Y, Lu Y, Wang L, Lu W, Huang J, Muir B, Yu J. Xu Y, et al. Colloids Surf B Biointerfaces. 2016 May 1;141:318-326. doi: 10.1016/j.colsurfb.2016.01.044. Epub 2016 Jan 28. Colloids Surf B Biointerfaces. 2016. PMID: 26874117

8

Targeted and synergistic therapy for hepatocellular carcinoma: monosaccharide modified lipid nanoparticles for the co-delivery of doxorubicin and sorafenib.

Duan W, Liu Y. Duan W, et al. Drug Des Devel Ther. 2018 Jul 11;12:2149-2161. doi: 10.2147/DDDT.S166402. eCollection 2018. Drug Des Devel Ther. 2018. PMID: 30034219 Free PMC article.

9

Negative-charge-functionalized mesoporous silica nanoparticles as drug vehicles targeting hepatocellular carcinoma.

Xie M, Xu Y, Shen H, Shen S, Ge Y, Xie J. Xie M, et al. Int J Pharm. 2014 Oct 20;474(1-2):223-31. doi: 10.1016/j.ijpharm.2014.08.027. Epub 2014 Aug 19. Int J Pharm. 2014. PMID: 25149125

10

Doxorubicin and curcumin co-delivery by lipid nanoparticles for enhanced treatment of diethylnitrosamine-induced hepatocellular carcinoma in mice.

Zhao X, Chen Q, Li Y, Tang H, Liu W, Yang X. Zhao X, et al. Eur J Pharm Biopharm. 2015 Jun;93:27-36. doi: 10.1016/j.ejpb.2015.03.003. Epub 2015 Mar 11. Eur J Pharm Biopharm. 2015. PMID: 25770771

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed